Supreme Court: Joint Disciplinary Proceedings Not Mandatory in Cases Involving Multiple Officers  ||  Supreme Court: Transferred Students Cannot Claim Government Fees After College Loses Recognition  ||  Supreme Court: Arbitration Clause Applies When Earlier Agreement is Imported “Body and Soul”  ||  J&K&L High Court: Seasonal Labourers Cannot Be Regularised Amid Government’s Blanket Ban  ||  Delhi High Court: Silence Amid Sustained Vilification May Undermine Public Confidence In Judiciary  ||  Calcutta HC Stays Eastern Railway Eviction Drive Affecting Around 6,000 Slum Dwellers Near Station  ||  J&K&L HC: Repeated Arrests U/S 107 Crpc After UAPA Bail Can be Fresh PSA Detention Grounds  ||  Del HC: Arrest Memo Listing Only Reasons Cannot Substitute Person-Specific Grounds of Arrest  ||  SC: Hostile Witness Testimony Can Support Acquittal as Well, Not Only Conviction  ||  SC: Appointing Candidates on Contract Against Advertised Regular Posts is Patently Illegal    

Cancer Research Initiative signed between India-UK - (14 Nov 2018)

Civil

The 5-year bilateral research initiative on cancer signed between India-UK. Initiative is launched by the Department of Biotechnology (DBT), Ministry of Science & Technology, India and Cancer Research UK (CRUK) focusing on affordable approaches to cancer. Both CRUK and DBT will invest £5m each and seek further investment from other potential funding partners. The India-UK Cancer Research Initiative was launched at the Inaugural Researchers’ Summit. The summit will facilitate knowledge sharing and communication among scientists, researchers, epidemiologists, clinicians, public health professionals and industry in the field of oncology.

The India-UK Cancer Research Initiative will identify a core set of research challenges that address issues of affordability, prevention and care of cancer by bringing together leading Indian and UK experts across clinical research, demographic research, new technologies and physical sciences. On the occasion, Secretary, DBT, Dr. Renu Swarup, said, “Cancer is a global epidemic that requires radically new approaches through inter-disciplinary and multi-national efforts. The India-UK Cancer Research Initiative will provide a catalysing platform for scientists and researchers in the UK and India to co-create solutions for affordable cancer care that improve cancer outcomes around the globe”. Nick Grant, Cancer Research UK’s executive director of international partnerships, said that no country escapes the impact of cancer, with millions around the world diagnosed with the disease every year and there is need to bring together the brightest scientific minds across the world, breaking down barriers to address the challenge of cancer globally.

The India-UK Cancer Research Initiative provides an opportunity to tackle the global epidemic of cancer by opening new pathways for international knowledge exchange and research base. The research outcomes of the initiative would aid cancer prevention, control and management in the long term. Strategic and evidence-based research partnerships would play a significant role in providing solutions to affordable cancer care.

Tags : MOU   RESEARCH INITIATIVE   CANCER  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved